The European Commission has granted orphan drug designation (ODD) for Poxel's PXL770 and PXL065 for the treatment of adrenoleukodystrophy (ALD). The decision follows a positive opinion from the Committee for...

View the Online Magazine

Launches

Shift to consumer-first mindset is highest priority for digital pharma products going into 2023

The new report from Graphite Digital – Overcoming Contradictions – reveals that moving to a consumer-first mindset when it comes to digital products is...

Peli BioThermal launches Crēdo™ Go cold chain shipping solution

Peli BioThermal, the life science industry’s partner from discovery to distribution, announces its newest reusable, flexible temperature controlled shipping solution. Crēdo™ Go is designed...

ACG to launch German process laboratory in 2023

Following the success of its first-to-market laboratory for process development in India, ACG (the world’s biggest integrated pharmaceutical and nutraceutical manufacturing solutions provider), is...

Suppliers Guide

Check out our Suppliers Guide or contact our team and get your company listed

Subscribe

Keep up with what's happening in the industry and subscribe to our weekly newsletter

Events

Get your event seen by potential candidates on the world's leading industry site.

Supply Chain

ACG: “The global pharmaceutical solutions company on a mission to help manufacturers keep their supply chains moving”

The current crisis in Europe has led to increasing energy insecurity and shortages of raw materials, which are creating severe pharmaceutical manufacturing supply line...

Advanco partners with Vantage to deliver the first interoperable pharmaceutical traceability solution

Advanco, one of the globe’s leading pharmaceutical track and trace solution providers, has announced the launch of ARC/QU4RTET, the pharmaceutical sector’s first open, interoperable,...

Shionogi signs agreement with NHS England to begin innovative subscription payment model for reimbursement of its antibiotic, Fetcroja (Cefiderocol)

Shionogi & Co., Ltd. and its European subsidiary, Shionogi B.V. (hereafter "Shionogi"), today announced that Shionogi B.V. had signed an agreement with NHS England...

Lupin Healthcare announces availability of the first carbon neutral pMDI with Luforbec® 100/6 (beclometasone 100 mcg / formoterol 6 mcg) and establishes commitment to...

Lupin Healthcare, the UK-based wholly owned subsidiary of Lupin Limited (Lupin), has announced that Luforbec (beclomethasone / formoterol) 100/6 pressurised metered dose inhaler (pMDI)...

Approvals

Alvotech and Bioventure’s AVT02 approved in Saudi Arabia

The Saudi Food & Drug Authority (SFDA) has approved the manufacturing and distribution of Alvotech and Bioventure's AVT02, a biosimilar for Humira (adalimumab), which is...

BRUKINSA receives marketing authorization for chronic lymphocytic leukemia and marginal zone lymphoma in Great Britain

The Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorizations for BeiGene's BRUKINSA (zanubrutinib) in Great Britain for both the treatment of...

Manufacturiung

Finance

Research & Development
Latest

Poxel receives orphan drug designation from European Commission for PXL770 and PXL065 for treatment of adrenoleukodystrophy

The European Commission has granted orphan drug designation (ODD) for Poxel's PXL770 and PXL065 for the treatment of adrenoleukodystrophy (ALD). The decision follows a positive...

New £1.6m research project to use AI to tackle antibiotic resistant infections

A researcher at the University of Nottingham has been awarded £1.6 million to look at how artificial intelligence (AI) could help us to tackle...

Avidity Biosciences granted FDA Fast Track designation for AOC 1020 for the treatment of facioscapulohumeral muscular dystrophy

Avidity Biosciences, a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs), has been granted Fast Track...

Orphagen receives Rare Pediatric Disease Designation from FDA for pediatric adrenocortical carcinoma treatment

The U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation (RPDD) for Orphagen Pharmaceuticals' OR-449 for the treatment of pediatric adrenocortical...

New research project awarded over £6m to spur on 3D printed medicines

A new research project has been awarded over £6m to develop a toolkit to allow 3D printed medicines to be manufactured effectively bringing innovations...

Appointments